California Gov. Newsom says the state is not going to do enterprise with Walgreens
California Gov. Gavin Newsom successfully defeated a recall attempt in California last year. When asked if he was preparing to run for president, Newsom insisted he wasn’t.
Justin Sullivan | Getty Images
California Gov. Gavin Newsom said Monday the state would no longer do business with him Walgreensafter the drugstore chain told 21 Republican attorneys general it would not sell the abortion pill in its states.
Newsom said on Twitter that the state was “done” with dealings with Walgreens. Brandon Richards, a spokesman for the governor, said California is reviewing all of Walgreens’ relationships with the state.
“We will not do business with companies that give in to right-wing bullies who are pushing their extremist agenda, or companies that prioritize politics over women’s and girls’ health,” Richards said.
Walgreens declined to comment.
The Food and Drug Administration in January allowed retail pharmacies to sell the abortion pill mifepristone if they are certified under an agency program that oversees how the drug is used and distributed.
Walgreens plans to become certified to sell mifepristone where legal under state and federal law, the company said. In February, 21 Republican attorneys general warned Walgreens not to ship mifepristone in their states.
Join us for CNBC’s Healthy Returns on March 29, where we’re hosting a virtual gathering of healthcare CEOs, scientists, investors and innovators to reflect on the advances made today in reinventing the future of medicine. We also have an exclusive look at the best investment opportunities in biopharma, healthcare technology and managed care. Learn more and register today: http://bit.ly/3DUNbRo
The company told attorneys general it would not sell or ship the pill in their states. Politico first reported the news.
Mifepristone, used in combination with another drug called misoprostol, is the most common method of abortion in the United States, accounting for about half of all abortions.
CNBC Health & Science
Read CNBC’s latest global health coverage:
Mifepristone has become a central issue in the fight for access to abortion after the Supreme Court’s Roe v. Wade had picked up.
A group of anti-abortion doctors have petitioned a Texas federal court to stay the FDA’s approval of mifepristone. On the other hand, Democratic attorneys general have asked a federal court in Washington to declare the FDA’s remaining restrictions on mifepristone unconstitutional.
The FDA approved mifepristone more than two decades ago, but the agency has imposed restrictions to ensure the pill’s safe use. The agency has gradually eased these restrictions over the years as more evidence of their safety and effectiveness accumulates.
The agency removed the requirement for patients to receive the pill in person at certain health facilities and allowed the drugs to be mailed. Patients still need a prescription from a healthcare provider that is FDA certified.
Comments are closed.